Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels.

Topisirovic I, Kentsis A, Perez JM, Guzman ML, Jordan CT, Borden KL.

Mol Cell Biol. 2005 Feb;25(3):1100-12.

PMID:
15657436
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth.

Topisirovic I, Culjkovic B, Cohen N, Perez JM, Skrabanek L, Borden KL.

EMBO J. 2003 Feb 3;22(3):689-703.

PMID:
12554669
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.

Topisirovic I, Guzman ML, McConnell MJ, Licht JD, Culjkovic B, Neering SJ, Jordan CT, Borden KL.

Mol Cell Biol. 2003 Dec;23(24):8992-9002.

PMID:
14645512
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The emerging roles of translation factor eIF4E in the nucleus.

Strudwick S, Borden KL.

Differentiation. 2002 Mar;70(1):10-22. Review.

PMID:
11963652
[PubMed - indexed for MEDLINE]
5.

eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3'UTR.

Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KL.

J Cell Biol. 2005 Apr 25;169(2):245-56. Epub 2005 Apr 18.

PMID:
15837800
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.

Topisirovic I, Ruiz-Gutierrez M, Borden KL.

Cancer Res. 2004 Dec 1;64(23):8639-42.

PMID:
15574771
[PubMed - indexed for MEDLINE]
Free Article
7.

Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.

Rousseau D, Kaspar R, Rosenwald I, Gehrke L, Sonenberg N.

Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1065-70.

PMID:
8577715
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A novel shuttling protein, 4E-T, mediates the nuclear import of the mRNA 5' cap-binding protein, eIF4E.

Dostie J, Ferraiuolo M, Pause A, Adam SA, Sonenberg N.

EMBO J. 2000 Jun 15;19(12):3142-56.

PMID:
10856257
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP.

Topisirovic I, Siddiqui N, Lapointe VL, Trost M, Thibault P, Bangeranye C, PiƱol-Roma S, Borden KL.

EMBO J. 2009 Apr 22;28(8):1087-98. doi: 10.1038/emboj.2009.53. Epub 2009 Mar 5.

PMID:
19262567
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Sodium arsenite-induced inhibition of eukaryotic translation initiation factor 4E (eIF4E) results in cytotoxicity and cell death.

Othumpangat S, Kashon M, Joseph P.

Mol Cell Biochem. 2005 Nov;279(1-2):123-31.

PMID:
16283521
[PubMed - indexed for MEDLINE]
11.

hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation.

Lynch M, Chen L, Ravitz MJ, Mehtani S, Korenblat K, Pazin MJ, Schmidt EV.

Mol Cell Biol. 2005 Aug;25(15):6436-53.

PMID:
16024782
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

eIF4E is a central node of an RNA regulon that governs cellular proliferation.

Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KL.

J Cell Biol. 2006 Nov 6;175(3):415-26. Epub 2006 Oct 30.

PMID:
17074885
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E.

Ge Y, Cheng R, Zhou Y, Shen J, Peng L, Xu X, Dai Q, Liu P, Wang H, Ma X, Jia J, Chen Z.

Mol Cell Biochem. 2012 Sep;368(1-2):17-25. doi: 10.1007/s11010-012-1338-3. Epub 2012 May 22.

PMID:
22614784
[PubMed - indexed for MEDLINE]
14.

Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer.

Topisirovic I, Siddiqui N, Orolicki S, Skrabanek LA, Tremblay M, Hoang T, Borden KL.

Mol Cell Biol. 2009 Mar;29(5):1152-62. doi: 10.1128/MCB.01532-08. Epub 2008 Dec 29.

PMID:
19114552
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

4E-BP3 regulates eIF4E-mediated nuclear mRNA export and interacts with replication protein A2.

Chen CC, Lee JC, Chang MC.

FEBS Lett. 2012 Jul 30;586(16):2260-6. doi: 10.1016/j.febslet.2012.05.059. Epub 2012 Jun 7.

PMID:
22684010
[PubMed - indexed for MEDLINE]
Free Article
16.

Eukaryotic translation initiation factor 4E is a cellular target for toxicity and death due to exposure to cadmium chloride.

Othumpangat S, Kashon M, Joseph P.

J Biol Chem. 2005 Jul 1;280(26):25162-9. Epub 2005 May 5.

PMID:
15878868
[PubMed - indexed for MEDLINE]
Free Article
17.

Initiation of mRNA translation in oncogenesis: the role of eIF4E.

Montanaro L, Pandolfi PP.

Cell Cycle. 2004 Nov;3(11):1387-9. Epub 2004 Nov 21.

PMID:
15492504
[PubMed - indexed for MEDLINE]
Free Article
18.

The HOX gene network in hepatocellular carcinoma.

Cillo C, Schiavo G, Cantile M, Bihl MP, Sorrentino P, Carafa V, D' Armiento M, Roncalli M, Sansano S, Vecchione R, Tornillo L, Mori L, De Libero G, Zucman-Rossi J, Terracciano L.

Int J Cancer. 2011 Dec 1;129(11):2577-87. doi: 10.1002/ijc.25941. Epub 2011 May 30.

PMID:
21626505
[PubMed - indexed for MEDLINE]
19.

Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.

Goldson TM, Vielhauer G, Staub E, Miller S, Shim H, Hagedorn CH.

Mol Carcinog. 2007 Jan;46(1):71-84.

PMID:
17091471
[PubMed - indexed for MEDLINE]
20.

Translation initiation factor 4E (eIF4E) is regulated by cell death inhibitor, Diap1.

Lee SK, Lee JS, Shin KS, Yoo SJ.

Mol Cells. 2007 Dec 31;24(3):445-51.

PMID:
18182863
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk